Condition: Pressure Ulcer, Stage IV · Osteomyelitis · Sponsor: Biocomposites Ltd
The purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibiotics to standard of care (debridement and systemic antibiotics only) for the treatment of osteomyelitis associated stage IV pressure ulcers.
This description comes directly from the study's public registry record.
Keira Watts, Clinical Research Director · +44 (0) 1782 338 580 · clinicaltrials@biocomposites.com
Daniel Roberts · droberts@mcra.com
Always discuss trial participation with your own doctor first.
| Advanced Foot Care, LLC | Phoenix, Arizona, United States | Recruiting |
| Northwestern University Feinberg School of Medicine | Chicago, Illinois, United States | Recruiting |
| Henry Ford Hospital | Detroit, Michigan, United States | Recruiting |
| University of Mississippi Medical Center | Jackson, Mississippi, United States | Recruiting |
| Missouri Orthopaedic Institute | Columbia, Missouri, United States | Recruiting |
| University of Nebraska Medical Center | Omaha, Nebraska, United States | Recruiting |
| Rutgers New Jersey Medical School | Newark, New Jersey, United States | Recruiting |
| NYU Langone Hospital - Long Island Clinical Research Center | Mineola, New York, United States | Recruiting |
| University of Pittsburgh, McGowan Institute for Regenerative Medicine | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06283979